Add this symposium to your calendar
Agenda
Welcome and Introduction
André Carvalho, MD, PhD, Brazil
SECTION 1: BIOSIMILARS
Development and Quality Standards of Biosimilars
Thomas Kirchlechner, PhD, Austria
Regulatory Uptake and the Impact on Healthcare Costs (UK example)
Catherine Smith, MD, United Kingdom
REGIONAL UPTAKE OF BIOSIMILARS
Europe
Adam Reich, MD, PhD, Poland
Asia
Yuling Shi, MD, PhD, China
Latin America
Fernando Valenzuela, MD, Chile
Africa
Olusola Ayanlowo, MSc, MD, Nigeria
Panel Discussion
Section 1 Faculty
Moderator: Errol Prens, MD, PhD, Netherlands
SECTION 2: TREATMENT OPTIMIZATION
Treatment Optimization
Paolo Gisondi, MD, Italy
Clinical Case: Treatment Optimization with Biologics or Biosimilars
Josep Riera-Monroig, MD, Spain
Clinical Case: Treatment Optimization with Combination Therapy
Maria-Angeliki Gkini, MD, MSc, PhD, FRCP, United Kingdom
Panel Discussion
Section 2 Faculty
Moderator: André Carvalho, MD, PhD, Brazil
Closing and Adjourn
Errol Prens, MD, PhD, Netherlands










